Applications Published 4 July 2001

Published: 8-Mar-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Processes and compsn for enhancing the action of vitamin A on the cellular activity of an individual and use of vitamin C
    Industria e Comercio de Cosmeticos Natura 1112059*

  • Drug preparations for treating sexual dysfunction
    LAM Pharmaceuticals 1112061*

  • Mousse compsn
    Soltec Research 1112062*

  • Lipstatin derivative-soluble fibre tablets
    SmithKline Beecham 1112063*

  • Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications.
    CLL Pharma 1112064*

  • Pharmaceutical compsn comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
    Orion Corp 1112065*

  • Use of methoxymorpholino doxorubicin for the treatment of a liver tumour
    Pharmacia & Upjohn 1112066*

  • Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compsns for the treatment of functional and/or organic pain syndromes
    Eisai 1112067*

  • Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
    Monsanto 1112068*

  • Medicament utilisation and combination
    Alphama-Isis; Schwartz Pharma 1112069*

  • Novel substituted triazole compounds
    SmithKline Beecham 1112070*

  • Growth hormone secretagogues
    Eli Lilly 1112071*

  • Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
    Sentron Medical; The Government of the United States of America as represented by the Secretary, Department of Health and Human Services 1112072*

    Calcilytic compounds
    SmithKline Beecham 1112073*

  • Taurolidine and/or taurultam against infectious ulcer or gastritis
    Ed Geistlich Soehne 1112074*

  • Compsns for the treatment of male erectile dysfunction
    Zonagen 1112075*

  • Polymeric compounds and methods of formulating same
    Chemeq 1112076*

  • Method for the detection of biological factors in epidermis.
    California Skin Research Institute 1112077*

  • New use
    Arencibia, Ignacio; Sundquist, Karl-Goesta 1112078*

  • Myrtle extract, preparation method and use
    Pierre Fabre Dermo-Cosmetique 1112079*

  • Regulation by HER2/NEU oncogene expression by synthetic polyamides
    California Institute of Technology 1112080*

  • Use of MCRP to slow cell growth and to promote maturation of cells
    Immtech International 1112081*

  • Stable liquid form of Botulinum toxin
    Elan Pharmaceutical 1112082*

  • Use of an angiogenic factor for the treatment of microvascular angiopathies
    Scios 1112083*

  • Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
    Idec Pharmaceutical 1112084*

  • Antithrombitic agent and humanised anti-Von Willebrand factor monoclonal antibody
    Ajinomoto 1112085*

  • Antibodies to C3B(I) for delivery of diagnostic and therapeutic agents to cancer cells
    The University of Virginia Patent Foundation 1112086*

  • Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefore
    Biogen 1112087*

  • Method for detecting, preventing and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor
    Henry Ford Health System 1112088*

  • Compsns comprising sympathomimetic amine salts unsuitable for illegal use
    Warner-Lambert 1112089*

  • Method of stimulating prosaposin receptor activity
    Myelos Corp 1112090*

  • Therapeutic compounds and methods
    Institute of Molecular and Cell Biology 1112250*

  • Azetidine derivatives, preparation and medicines containing them
    Aventis Pharmna 1112251*

  • Kappa agonist compounds and pharmaceutical formulations containing them
    Adolor Corp 1112252*

  • Branched alkyl pyrrolidine-3-carboxylic acids
    Warner-Lambert 1112253*

  • Cyanine dyes and synthesis methods thereof
    NEN Life Science Products 1112254*

  • 4,4-biarylpiperidine derivatives with opioid receptor activity
    Pfizer Products 1112255*

  • Method for producing a stabilised aqueous alkali metal-2-hydroxy-4,6-dichloro-S-triazine solution and the use thereof.
    SKW Trostberg 1112256*
  • You may also like